Lauren DAngelo
Chief Operating Officer chez ALPHA COGNITION INC.
Postes actifs de Lauren DAngelo
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALPHA COGNITION INC. | Chief Operating Officer | 01/01/2023 | - |
Corporate Officer/Principal | 04/05/2021 | - |
Historique de carrière de Lauren DAngelo
Anciens postes connus de Lauren DAngelo
Sociétés | Poste | Début | Fin |
---|---|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Sales & Marketing | - | - |
Formation de Lauren DAngelo
Florida State University | Undergraduate Degree |
University of Florida | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 4 |
Canada | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALPHA COGNITION INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Bourse
- Insiders
- Lauren DAngelo
- Expérience